Vincent Q1*, Roxane F1, Aurelie L1 and Nicolas M2
1Department of Ophthalmology, UCLouvain, UCLouvain Catholic University of Louvain, Belgium
2Department of Otorhinolaryngology, UCLouvain, UCLouvain Catholic University of Louvain, Belgium
Background: Epiphora in adults is a frequent ophthalmological condition with multiple etiologies, and requires a multidisciplinary approach for management, diagnosis and treatment, combining ophthalmologists, ENTs, nuclear medicine specialists, radiologists. Few centers possess a truly multi-specialty method for analyzing and treating epiphora in adults. Materials and Methods: We have conducted a retrospective study on 57 patients with a follow-up of 12 months, to examine the different etiologies and treatments in a multidisciplinary epiphora clinic in a tertiary care setting. Patients were systematically examined by an ophthalmologist and an ENT specialist, in addition to a full epiphora clinical workup. If needed, they were then referred for additional examinations in radiology (dacryo cone beam scanner) or scintigraphy. Results: Obstruction at any stage of the lacrimal drainage system was the most common cause of epiphora (48%), followed by ocular surface disease (28%), then eyelid malposition or laxity (26%), and finally functional causes. Regarding treatments, 10.5% (n=6) of patients underwent 3-snip punctoplasty, 8% (n=5) underwent canalicular repermeabilization through sharp catheterization, 21% (n=12) underwent DCR, 42% (n=24) were prescribed lid hygiene or ocular lubrication, 21% (n=12) underwent eyelid surgery through canthopexy, 1% (n=1) had a combined treatment and 19% (n=11) had no treatment. Discussion: A multidisciplinary collaboration is crucial in epiphora management. In addition, our results are in line with the etiology distributions found in the literature.
Vincent Q, Roxane F, Aurelie L, Nicolas M. Etiology and Management of Epiphora in the Adult Patient: A Retrospective Study in an Interdisciplinary Epiphora Clinic. J Clin Ophthalmol Eye Disord. 2021; 5(1): 1032.